Neumora Therapeutics (NMRA) Long-Term Investments (2022 - 2024)

Neumora Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $302000.0 for Q1 2024.

• In Q1 2024, Long-Term Investments changed N/A year-over-year to $302000.0; the TTM figure through Mar 2024 stood at $302000.0 (changed N/A YoY), while the FY2023 annual figure was $9.8 million, down 58.13% from the prior year.
• Long-Term Investments was $302000.0 for Q1 2024 at Neumora Therapeutics, down from $9.8 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $23.5 million in Q4 2022 to a low of $302000.0 in Q1 2024.
• Historically, Long-Term Investments has averaged $10.9 million across 3 years, with a median of $9.9 million in 2023.
• Biggest YoY gain for Long-Term Investments was 58.13% in 2023; the steepest drop was 58.13% in 2023.
• A 3-year view of Long-Term Investments shows it stood at $23.5 million in 2022, then slumped by 58.13% to $9.8 million in 2023, then sank by 96.93% to $302000.0 in 2024.
• The last three Long-Term Investments figures came in at $302000.0 (Q1 2024), $9.8 million (Q4 2023), and $9.9 million (Q3 2023), per Business Quant data.